Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

for
Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03128034

Phase 1, Phase 2, Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

for
Hodgkin Lymphoma, Relapsed or Refractory Hodgkin Lymphoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT03618550

Phase 2, Recruiting

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

for
Primary Central Nervous System Lymphoma,
Location: Miami FL
Sponsor: Baptist Health South Florida

Sex: All

Age: 18+

Code: NCT05681195

Phase 2, Recruiting

Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial

for
Myelomeningocele
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 0

Code: NCT04652908

Phase 1, Phase 2, Recruiting

Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease

for
Peripheral Vascular Diseases
Location: Indianapolis IN
Sponsor: Murphy, Michael P., MD

Sex: All

Age: 21 - 70+

Code: NCT00113243

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

for
B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05432635

Phase 1, Recruiting

Autologous Stem Cell Transplantation for Crohn's Disease

for
Crohn's Disease
Location: Pittsburgh PA
Sponsor: Paul Szabolcs

Sex: All

Age: 10 - 60

Code: NCT00692939

Phase 1, Phase 2, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for
AL Amyloidosis
Location: Boston MA, Guilford CT, Hartford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase 3, Recruiting

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

for
Splenomegaly, Myelofibrosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06345495

Phase 2, Recruiting

Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

for
Non-Hodgkins Lymphoma
Location: Montreal
Sponsor: Maisonneuve-Rosemont Hospital

Sex: All

Age: 18 - 65

Code: NCT00807196

Phase 1, Phase 2, Recruiting

Stem Cell Transplantation in Crohn's Disease

for
Crohn Disease
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 13 - 28

Code: NCT04224558

Phase 1, Phase 2, Recruiting

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

for
AML, ALL, Lymphoid Malignancies, Myelodysplastic Syndromes, CML,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 0 - 70+

Code: NCT06047886

Phase 1, Recruiting

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06735690

Early Phase 1, Recruiting

RAPA-501 Therapy for ALS

for
Amyotrophic Lateral Sclerosis
Location: Boston MA
Sponsor: Rapa Therapeutics LLC

Sex: All

Age: 18+

Code: NCT04220190

Phase 2, Phase 3, Recruiting

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

for
Diffuse Large B Cell Lymphoma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT06687772

Phase 2, Recruiting

Treatment of Perianal Disease Using Adipose-derived Stem Cells

for
Perianal Fistula, Crohn Disease
Location: San Diego CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT03913572

Recruiting

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

for
PD - Parkinson's Disease
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 40 - 70+

Code: NCT06482268

Phase 1, Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

for
Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 50

Code: NCT03980769

Phase 2, Recruiting

The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

for
Knee Osteoarthritis
Location: Denver CO, Santa Monica CA
Sponsor: University of Colorado, Denver

Sex: All

Age: 35 - 70

Code: NCT03014401

Recruiting

Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI

for
Spinal Cord Injury (SCI)
Location: San Diego CA
Sponsor: Neuralstem Inc.

Sex: All

Age: 18 - 65

Code: NCT01772810

Phase 1, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial